Jiameihui (Chongqing) Trading Co., Ltd. – Trademark Portfolio

Entity Type: 99

Jiameihui (Chongqing) Trading Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include CUGUNEO. The owner is based in Chongqing.

(For office use only) No. 86, Annex 1, Building 2, No. 369 Jinhua Road, Beibei District

Chongqing 400050 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

CUGUNEO
CUGUNEO
Registered 2025

Trademark Classifications

Jiameihui (Chongqing) Trading Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Jiameihui (Chongqing) Trading Co., Ltd. have?

Jiameihui (Chongqing) Trading Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Jiameihui (Chongqing) Trading Co., Ltd. file in?

Jiameihui (Chongqing) Trading Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Jiameihui (Chongqing) Trading Co., Ltd.'s most well-known trademarks?

Jiameihui (Chongqing) Trading Co., Ltd.'s registered trademark portfolio includes well-known marks such as CUGUNEO. These are among 1 currently registered trademark in the portfolio.

What is Jiameihui (Chongqing) Trading Co., Ltd.'s trademark registration success rate?

Jiameihui (Chongqing) Trading Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.